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Abstract Much of our understanding of themolecular control
of menstruation arises from laboratory models that experimen-
tally recapitulate some, but not all, aspects of uterine bleeding
observed in women. These models include: in vitro culture of
endometrial explants or isolated endometrial cells, transplan-
tation of human endometrial tissue into immunodeficient mice
and the induction of endometrial breakdown in appropriately
pretreated mice. Each of these models has contributed to our
understanding of molecular and cellular mechanisms of men-
struation, but nonhuman primates, especially macaques, are
the animal model of choice for evaluating therapies for men-
strual disorders. In this chapter we review some basic aspects
of menstruation, with special emphasis on the macaque model
and its relevance to the clinical issues of irregular and heavy
menstrual bleeding (HMB).
Keywords Macaque . Menstruation . Model . Hormonal
control . Menstrual blood loss . Endometrium . Cervix .
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1 Introduction
Much of our understanding of the molecular control of
menstruation arises from laboratory models that experimen-
tally recapitulate some, but not all, aspects of uterine bleed-
ing observed in women. These models include: in vitro
culture of endometrial explants or isolated endometrial cells
[1–3], transplantation of human endometrial tissue into
immunodeficient mice [4], and the induction of endometrial
breakdown in appropriately pretreated mice [5–8]. Each of
these models has contributed to our understanding of molec-
ular and cellular mechanisms of menstruation, but nonhuman
primates, especially macaques, are the animal model of choice
for evaluating therapies for menstrual disorders. In this chap-
ter we review some basic aspects of menstruation, with special
emphasis on the macaque model and its relevance to the
clinical issues of heavy and irregular menstrual bleeding.
Menstrual disorders including heavy menstrual bleeding
(HMB), irregular uterine bleeding, and painful menstruation
are common problems experienced by many women. HMB
is considered as excessive menstrual blood loss, prolonged
more than 8 days, which interferes with the woman’s phys-
ical, emotional, social and material quality of life, and which
can occur alone or in combination with other symptoms [9].
Irregular menstruation is characterized by cycles that vary
more than 8 days in length. HMB affects approximately
one-third of reproductive aged women and although heavy
bleeding can be associated with endometriosis and uterine
fibroids, greater than 80 % of patients with HMB exhibit no
clear underlying cause [10]. Idiopathic HMB is one of the
most common gynecologic conditions requiring hospitaliza-
tion, and 20–30 % of all hysterectomies are performed to
stop abnormal bleeding. Expansion of medical therapies for
HMB would greatly benefit the health of many women who
cannot or do not wish to undergo surgery [11].
2 Phylogenetic considerations
Periodic uterine bleeding is reported for a small number of
non-primate mammals, including some species of tree shrew
[12]. However, cyclic, hormonally regulated shedding of the
endometrium, characteristic of truemenstruation, is found only
in a few species of bats [13, 14] and in primates, including
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Homo sapiens, the Great Apes (Hominidae), Lesser Apes
(Hylobatidae) and Old World monkeys (Cercopithecidae)
[15]. In these primate species, menstruation follows the fall
in progesterone levels as the corpus luteum regresses at the end
of the ovarian cycle, and cycle lengths are counted from the
first day of menstrual bleeding. Menstrual cycle length varies
slightly between primate species, from about 28 days in women
and rhesus macaques to about 37 days in chimpanzees. Rhesus
(Macaca mulatta), cynomolgus (Macaca fascicularis), and
pigtailed macaques (Macaca nemestrina) display approxi-
mately 28 day menstrual cycles, similar to those of women
[16–18]. Rhesus macaques are the most widely used nonhu-
man primate model for menstrual bleeding studies [19–21].
Macaques can be trained to allow daily vaginal swabs to
detect menstrual bleeding [21] and can be fitted with tampons
[22] for more quantitative analysis of menstrual blood loss.
Naturally cycling macaques may display spontaneous men-
strual disorders, including irregular bleeding and HMB
(Fig. 1), making them ideal for clinically relevant studies.
Further, macaques can be ovariectomized and treated with
ovarian steroids to induce artificial menstrual cycles. Induced
cycles reduce the variability inherent in natural cycles, and
permit endometrial sampling during precisely defined pre-
menstrual, menstrual and postmenstrual phases.
3 Anatomical considerations
The macaque uterus is morphologically similar to the human
uterus, consisting of the fundus (dome-shaped top), corpus
(body), and isthmus (neck) leading to the cervix. The endo-
metrium lines the uterine cavity and is surrounded by the
muscular wall or myometrium (Fig. 2a). In women [23] and
macaques [24] the endometrium has 4 layers or “zones”
extending from the luminal surface to the myometrial border.
In that classification, the luminal epithelium and an
underlying band of stromal cells is defined as Zone I.
Slightly deeper, Zone II contains glands that run perpendic-
ular to the surface. Zones I and II are sometimes referred to as
the “compacta” in women and consist of densely packed
stromal cells around the straight necks of the glands. Deeper
still, Zone III, sometimes referred to as the spongiosa in
women, contains glands that are branched. The deepest zone,
Zone IV, the basalis, is adjacent to the myometrium, where the
glands terminate (Fig. 3). The upper zones (e.g. the compacta
and upper spongiosa) are also referred to as the functionalis, or
functional layer, as opposed to the basalis, or basal layer. The
functionalis, which undergoes secretory transformation under
the influence of progesterone, derives its blood supply from
specialized spiral arteries rather than the basal arteries that
supply the deepest, basal zone [25]. The spiral arteries are
unique endometrial vessels in menstruating primates that
undergo hormonally driven regeneration after menstruation
in each cycle. In the secretory phase, progesterone stimulates
spiral artery hypertrophy, and during a fertile cycle these
arteries play an important role in embryo implantation.
Abnormal spiral arteriogenesis can contribute to pregnancy
failure and may lead to breakthrough bleeding and HMB [26].
While the macaque uterus is strikingly similar to that of
most other Old World nonhuman primates, the anatomy of the
cervix varies greatly between primate species [27]. In baboons
[28] ( as in women) the cervical canal is relatively free from
obstruction, which facilitates hysteroscopy for the assessment
of endometrial bleeding and collection of samples by curettage
Fig. 1 Comparison of normal
versus disordered and heavy
menstrual bleeding (HMB) in
rhesus macaques. Top panel:
bleeding patterns of 8 animals
with normal cycles. Bottom
panel: bleeding patterns of 6
animals with abnormal cycles.
Each row shows the days of
bleeding of one animal fol-
lowed for 110 days, aligned by
the first day of bleeding.
The lower panel shows the
erratic bleeding patterns of
monkeys with menstrual
disorders including irregular
bleeding and HMB
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[29–31]. However, in macaques there is a prominent collicu-
lum (Fig. 4) that obstructs passage of instruments into the
uterine cavity [32]. Estrogen stimulation induces increased
curvature that further restricts access to the cervical canal.
4 The macaque menstrual cycle
Central regulation of female sexual maturation, follicular
development, ovulation, and ovarian hormone secretion in
primates involves interplay between the hypothalamus, pi-
tuitary and ovary, relationships that have been reviewed
extensively [33–35]. In primates, ovarian cyclicity is not
dependent on endocrine feedback from the uterus. Es-
tradiol (E) and progesterone are the only ovarian factors
required for induction of menstruation [36–38]. Briefly,
the menstrual cycle can be divided into three phases: the
menstrual phase, the follicular (or proliferative) phase, and
the luteal (or secretory) phase. Estradiol secreted by the
ovary during the follicular phase stimulates cell prolifer-
ation in both the endometrial glands and stroma [39]. In
macaques the length of the proliferative phase of the natural
cycle is normally 10–14 days. After ovulation, progesterone
levels rise during the luteal phase [39] of the cycle, which
usually lasts for 12 to 14 days. If pregnancy does not occur,
the corpus luteum regresses and the decline of progesterone
triggers menstruation .
In various studies, we induced cycles in ovariectomized
macaques by treating the animals with Silastic capsules that
release E and progesterone [40]. Briefly, animals are treated
first with E alone, which stimulates an artificial proliferative
phase, characterized by tubular endometrial glands and
Fig. 2 Comparison of rhesus uterus in proliferative versus menstrual
phase. Freshly removed uteri were cut in half along the fundal-cervical
axis and photographed with macro lenses. a a dark line marks the
endometrial-myometrial border and another line delineates the plane
along which sections of the endometrium were cut. This specimen was
taken on day 14 of the induced proliferative phase. Endo 0 endome-
trium. Myo 0 myometrium. b on day 2 of the menstrual cycle, bleeding
is restricted to the upper third of the endometrium. The basalis and the
lowest part of the functionalis does not bleed or slough. Scale bar0
1 cm; applies to both images
Fig. 3 Histology of the rhesus
endometrium in the
proliferative, secretory and
menstrual phases. Histological
sections of the endometrium
were cut on a plane running
from the luminal to the
myometrial border. Straight
versus tortuous glands are
evident in (a versus b). Sections
taken during the menstrual
phase (c–e) show that menstrual
breakdown is only evident in
the functionalis (c–d) not the
basalis (e). Scale bar for
a–c01 mm; scale bar
for d–e0100 μm
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abundant proliferating cells in the glandular epithelium.
After 14 days of E priming, addition of a progesterone
capsule induces an artificial secretory phase, which becomes
evident by day 3 of progesterone treatment. Progesterone
acts to gradually suppress cell proliferation in the glandular
epithelium, which thickens, and the glands become saw-
toothed and sacculated in appearance, with shrunken nuclei
and jagged apical surfaces. In the macaque, the early secre-
tory phase is marked by a striking up regulation of cell
proliferation in the glands of the basalis zone [41, 42].
Withdrawal of the progesterone capsule (with E left in
place) completes the cycle and induces menses on days 2–5
of the next cycle. We refer to this 2–5 days interval as the
luteal-follicular transition (LFT) [43, 44].
The effects of ovarian steroid hormones on estrogen and
progesterone receptors have been extensively reviewed
[45–47]. Briefly, during the proliferative phase, E stimulates
expression of estrogen receptor-1 (ESR-1) and progesterone
receptor (PGR) in the endometrial glandular epithelium and
stromal fibroblasts. During the secretory phase, progester-
one suppresses ESR-1 in glands and stroma of the functio-
nalis zone, while suppressing PGR only in the glands, not
the stroma. Thus, progesterone can act through PR in the
stromal fibroblasts to control expression of tissue degrading
enzymes, growth factors, and extracellular matrix mole-
cules. The basalis zone is unique in retaining both ESR-1
and PGR in both the glands and stroma during the secretory
phase. The vascular endothelium in all zones fails to
expresses ESR-1 or PGR but does express ESR-2 (ER-beta
[45, 48]).
Endometrial angiogenesis, vascular growth, and vasocon-
striction [49, 50] have been extensively studied in macaques
[51, 52] because the vessels of the upper functionalis are shed
and regenerated after menstruation. Endothelial cell prolifera-
tion peaks in small vessels during the proliferative phase [51,
53]. After ovulation, the endometrial spiral arteries hypertrophy
[42], and provide increased blood flow [54] to the upper zones
where embryo implantation and early placentation occur [55].
The effects of progesterone on the spiral arteries are probably
mediated by factors arising from PGR-positive stromal cells or
through novel non-nuclear receptors [56]. At the end of a
nonfertile cycle the fall in progesterone triggers waves of
vasoconstriction [57] of the spiral arteries typically followed
4 to 24 h later by menstruation.
5 Histological aspects of menstrual breakdown
On day 28 of an induced cycle, the endometrium appears
thickened with stromal cell hypertrophy, tissue edema and
tortuous glands in the functionalis zone. Twenty four hours
after progesterone withdrawal the endometrium shrinks dra-
matically and the stroma becomes highly compacted. By
day 2 the uppermost third of the endometrium undergoes
extensive fragmentation accompanied by hemorrhage and
sloughing (Fig. 2b). The deeper functionalis and basalis
zones show no signs of fragmentation, but the glandular
epithelial cells in the basalis undergo extensive apoptotic
cell death during days 2–6.
Overt menstrual bleeding typically ends on day 4–6, and
around day 5 mitotic activity begins in the necks of the sur-
viving glands [44]. By day 8 there is increased endometrial
growth of the glands as well as maximal endothelial cell
proliferation [51]. Structural regrowth of the endometrium in
the follicular phase appears complete by day 10–14, at which
time the endometrium consists of straight, nonsacculated tubu-
lar glands encompassed within a moderately loose stroma.
6 Effects of progesterone withdrawal on endometrial
matrix metalloproteinases
The decline of progesterone at the end of the cycle is
followed by increased expression of tissue degrading matrix
metalloproteinase (MMP) enzymes [19, 58]. The MMPs
have the enzymatic capability to mediate tissue dissolution
in the upper functionalis zones and are considered primary
effectors of menstrual sloughing [59, 60]. MMPs are a
multigene family of enzymes that require zinc for their
activation [61] . Secreted as proenzymes, the MMPs under-
go activation to a catalytically active form in the endometri-
um. Enzyme activation is regulated by specific endogenous
tissue inhibitors of metalloproteinases (TIMPs) [61] that are
also expressed in the endometrium [62, 63]. In vitro studies on
endometrial stromal cells in culture demonstrate that proges-
terone suppresses expression of several MMPs [59, 64]. Par-
adoxically, progesterone receptor consensus sequences have
not been identified on the MMPs associated with menstrua-
tion. Moreover, in the macaque, endometrial expression of
Fig. 4 The rhesus macaque cervix. A cervix was freshly removed
from a rhesus macaque at midcycle and cut longitudinally along the
axis from the External os to Internal os. A projection of the cervical
wall (colliculum) forces the cervical canal into a Z-shaped path. Scale
bar01 cm
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several MMPs declines rapidly after menstruation, well before
progesterone levels increase [19]. Therefore, progesterone
mediated regulation of MMPs appears to be either indirect
through paracrine/autocrine factors, or through non-traditional
mechanisms. Because of the focal nature of menstrual break-
down and the restriction of MMP expression to the mid and
upper functionalis zones, it has been suggested that local
factors such as specific cytokines can regulate endometrial
MMPs. For instance, TGF-beta has been identified as a me-
diator of MMP-7 suppression by progesterone [65]. Also,
endometrial bleeding associated factor (ebaf; lefty-A) has
been identified as an inhibitor of TGF-beta [66], and
lefty-A can induce expression of several MMPs in human
endometrial stromal cells. Because progesterone can still
suppress MMPs upregulated by lefty-A in vitro [67], the
mechanism throughwhich progesterone regulates endometrial
MMPs remains unclear.
In earlier studies we documented the timing of menstrual
sloughing and the expression of various MMP enzymes in
rhesus and pigtailed macaques [19, 40]. For these studies the
animals were treated with E and progesterone to induce
artificial menstrual cycles, and the uterus was removed from
the animals on days 1,2,3,4,5,6,8,10,14,21 and 28 of the
cycle. In this design, day 0 represents the day of progester-
one implant removal. In other animals we removed both the
E and the progesterone releasing capsules to determine
whether the absence of E would affect MMP expression.
These latter animals were referred to as either spayed or
hormone-deprived. In each case, samples of endometrium
were prepared for immunocytochemistry and analysis of
MMP mRNA expression. In general, the expression of
endometrial MMPs in vivo during the menstrual cycle of
the rhesus macaque was very similar to that reported for
women. Most of the MMPs were expressed at relatively
high levels just before and during menstrual breakdown
(Fig. 5). Immunolocalization studies revealed strong stain-
ing for MMP-1, MMP-2, and MMP-3, localized primarily to
the stromal cells of the fragmenting zones, with intense
staining in the cytoplasm of stromal cells at the basement
membrane of regressing spiral arteries. Immnocytochemical
staining patterns of MMP-2 are illustrated in Fig. 6. MMP-7
was initially expressed by the glands immediately below the
fragmenting zone, and later in the upper glands as the
endometrium entered the repair phase. MMP-7 localiza-
tion became stronger as MMP-2 and MMP-3 staining
waned in the early follicular phase. Tissue inhibitor of
metalloproteinases-1 (TIMP-1) also increased, at both the
protein and gene expression level, by cycle day 2. This in-
crease was especially apparent in the smooth muscle and
perivascular stroma of the spiral arteries and in large numbers
of stromal cells in the fragmenting and sloughing endometrial
regions. All these effects were similar in the presence and
absence of E.
Several studies have proposed that induction of menstru-
ation occurs in two phases [21, 68, 69]. In the first phase,
progesterone withdrawal initiates up regulation of specific
paracrine regulators, especially those secreted by the peri-
vascular cells of the spiral arteries. Once these regulators are
fully expressed, a second phase dominated by tissue degrad-
ing enzymes develops. A corollary of this hypothesis is that
the first, but not the second phase can be interrupted by re-
elevation of progesterone [21]. This suggests that progester-
one withdrawal is followed by a “critical period” after which
tissue breakdown, sloughing and bleeding become inevita-
ble. To further define the critical period in macaques, we
induced cycles as described above and, at the end of the
luteal phase, withdrew progesterone at time 0 and then
either replaced progesterone (or not) 12, 24, or 48 h later.
Uteri from experimental (progesterone-replaced) and con-
trol (not replaced) animals were collected 36, 48 and 72 h
after progesterone withdrawal (n03/interval). Strong immu-
nocytochemical staining for MMP-1 and MMP-2 was
evident in controls at 36, 48 and 72 h. Progesterone replace-
ment at 12–24 h after P withdrawal (the critical period),
blocked menses and blocked expression of both MMPs.
This confirms a role for both MMP-1 and MMP-2 in the
initiation of menstruation. However, progesterone replace-
ment after the critical period failed to suppress menses and
failed to suppress MMP2, though MMP-1 was suppressed.
Therefore, some MMPs may be more important for initiat-
ing menses, and others for sustaining menstrual breakdown.
Our results confirm and extend the view that there is a
physiologically significant critical period underlying the
menstrual process. The particular role that each MMP plays
in the menstrual cascade remains to be determined.
7 Vascular events associated with menstruation
Much of our understanding of menstruation arises from
classical studies by Markee [49]. Markee transplanted rhe-
sus macaque endometrium to the anterior chamber of the
eye and visualized the events of menstruation directly. He
observed pulses of vasoconstriction in the spiral arteries
after progesterone withdrawal that could lead to localized
ischemic hypoxia in the superficial zones. Vascular endothe-
lial growth factor (VEGF) is reported to be upregulated by
hypoxia in the human endometrium [70], and in our macaque
studies, stromal and glandular VEGF were dramatically up
regulated premenstrually. VEGF may interact with several
receptors, includingVEGFR-1 andVEGFR-2which are located
on the membranes of endothelial cells [71, 72]. However,
VEGFR-2 expression was also upregulated by progesterone
withdrawal in the stromal cells of the functionalis zone.
Whether VEGF interacts with VEGFR-2 in these stromal cells
after progesterone withdrawal remains to be determined.
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Fig. 5 mRNA expression of various MMPs in the rhesus menstrual
cycle. Plots of northern hybridization data reveal two patterns of MMP
mRNA expression. Top Row: Certain MMPs were strongly expressed
during the menstrual phase and declined to minimal levels by days 5–6.
Bottom Row: Other MMPs peaked similarly during menstruation but
declined much more slowly
Fig. 6 Immunohistochemistry
of MMP-2 during the prolifera-
tive phase. Endometrial sections
were stained for MMP-2 on days
(D) 0,1,2,3,4 and 14 after P
withdrawal. The black line
marks the myometrial border.
Strong dark brown staining for
MMP-2 protein was confined to
the upper functionalis zone dur-
ing the menstrual phase (D1-4).
The staining became nondetect-
able by day 14. Scale bar01mm;
applies to all images
314 Rev Endocr Metab Disord (2012) 13:309–318
We also examined the expression and localization of
hypoxia inducible factor 1 (HIF-1α) in the rhesus macaque
endometrium during the menstrual-early proliferative stage
of an induced cycle. HIF-1α is a nuclear protein that
mediates the effects of hypoxia on gene expression. Artificial
cycles were induced in 26 ovariectomized rhesus macaques.
After 14 days the P implant was removed and the uterus was
collected from 2 animals each on days 0, 1, 2, 3, 4, 5, 6,
8 and 14 (P withdrawn). In another group, the P and E
implants were both withdrawn on day 0 and the uteri were
collected on days 1, 2, 3, and 14 (hormone deprived).
Menses occurred in both groups on days 2–5. Endometrial
samples were analyzed for HIF-1 mRNA by Northern blot
and in situ hybridization . Northern blots revealed that HIF-
1α mRNA levels were low on day 0, increased strikingly on
days 1–3 of the cycle and then declined. Similarly, in the
hormone-deprived group, the HIF-1α mRNA increased on
days 1 and 2 and then declined. These increases occurred
primarily in the glands and the small blood vessels of the
upper functionalis zone. Grain counts of the ISH prepara-
tions showed a 6.6 fold increase in the blood vessels and a
1 .4 fold increase in the glands over baseline during days 1
and 2 followed by a decline. Immunocytochemical staining
of the HIF-1α nuclear protein showed a similar pattern of
expression (Fig. 7). In sum, HIF-1α was strikingly elevated
in endometrial vessels and glands in the functionalis on days
1–3 after P withdrawal whether or not E was present. These
data support a role for hypoxia, mediated by HIF-1α, in the
early phases of the menstrual cascade.
8 Endometrial repair
Much more is known about the destructive sloughing of the
menstrual process than the reconstructive processes involved
Fig. 7 Immunohistochemistry of hypoxia inducible factor in the ma-
caque endometrium. Endometrial sections were stained for hypoxia
inducible factor protein on days 0, 2,3, and 8 after P withdrawal. A
mouse monoclonal antibody against HIF-1α at a concentration of
1:1000 (Novus Biologicals) was used. Nuclear HIF-1α staining was
low on day 0, increased strikingly on days 1–3 of the cycle and then
declined to undetectable by day 8. These increases occurred primarily
in the glands and the small blood vessels of the upper functionalis
zone, presumably in response to local hypoxia. Scale bar050 um;
applies to all images
Fig. 8 Mean menstrual blood loss over 6 days in artificially cycled
macaques. Menstruation peaked in all animals on day 3 after proges-
terone withdrawal. Short (21 days) menstrual cycles had no significant
effect on total menstrual blood loss compared to normal length
(28 days) cycles, but treatment with artificially amplified cycles
(35 days) in which the secretory phase had elevated and prolonged
exposure to progesterone resulted in increased bleeding (P<0.01).
Treatment with antifibrinolytics including tranexamic acid (TXA;
75 mg/kg/day) or ε-aminocaproic acid (EACA; 100 mg/kg/day) sig-
nificantly reduced menstrual blood loss (P<0.05). Values were com-
pared statistically by Analysis of Variance and means were compared
by Fisher’s protected LSD
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in menstrual repair. These include re-epithelialization, surface
healing and cessation of bleeding. Immediately after menstru-
ation the endometrial surface is ragged and torn with multiple
gland openings surrounded by denuded stromal elements [73].
Healing of this denuded stromal surface begins with the
transformation of the uppermost gland cells into a migratory
phenotype. Cells move from the necks of the glands, spread
out over the raw suface, meet migrating cells from other
glands and combine with them to form a new luminal surface.
By day 5, estrogen driven mitotic activity begins in the necks
of the glands [44].
The underlying cellular and molecular mechanisms that
support this form of endometrial “wound healing” are not
understood. In other wounded tissues, particularly skin [74],
a variety of molecules including fibronectin, various colla-
gens, laminin and vitronectin are involved in the healing
process . Fibronectin is a large fibrillar glycoprotein, secreted
usually as a homodimer, composed of two ~250 kDa mono-
mers linked together by a pair of disulphide bonds. Interac-
tions between fibronectin and specific integrins are known to
enhance cell adhesion and migration during wound healing
[75–77]. In a recent study, [78], we analyzed samples of
rhesus macaque endometrium with pathway-focused arrays
of human genes associated with the extracellular matrix and
found that fibronectin and integrin β1 transcripts were dra-
matically increased during menstruation and repair, compared
to the late secretory phase of the cycle. The results showed that
fibronectin and specific fibronectin receptors increased dra-
matically during menstruation and repair and that these mol-
ecules were only expressed in the uppermost endometrial
zones. Additional research on the related factors in the extra-
cellular matrix is needed to further define endometrial “wound
healing”, a process that is highly relevant to the clinical
problem of uncontrolled endometrial bleeding.
9 Studies of menstrual blood loss
Recently we utilized a rigorous method for measuring menstru-
al blood loss in rhesus macaques. Macaque-size tampons were
devised and used to collect the menstrual flow. Tampons were
removed daily, vacuum dried and mixed with 5 % sodium
hydroxide. The resulting alkaline haematin extract was quanti-
fied spectrophotometrically at 564 nm on Elisa plates. Average
total blood loss during the menstrual cycle in 11 animals was
5.87 +/− 0.6 ml (over 6 days). Removal of the tampons daily
revealed that menstrual blood loss peaked in all the animals on
day 3 after progesterone withdrawal. To assess the effects of
ovarian hormones on menstrual blood loss, we manipulated
both the serum level of progesterone and the length of the
secretory phase. Short menstrual cycles were created by treating
the animals with progesterone (5–6 ng/ml) for 7 days. Normal
menstrual cycles had similar levels of progesterone for 14 days.
Extended 35 day menstrual cycles had 2 progesterone implants
that produced 11–13 ng/ml for 21 days. Interestingly, treatment
with short cycles had no significant effect on total menstrual
blood loss compared to normal length cycles (Fig. 8). In con-
trast, treatment with extended cycles with elevated progesterone
resulted in significantly greater menstrual blood loss (Fig. 8).
We also treated animals with two anti-fibrinolytic therapies,
tranexamic acid (TXA) or ε-aminocaproic acid (EACA;) be-
ginning on cycle day 0 for 5 days. Both significantly reduced
menstrual blood loss. We will evaluate alternative therapies for
ameliorating menstrual blood loss in rhesus macaques with a
similar quantitative approach.
10 Conclusion
In sum, the rhesus macaque has contributed significantly to
our understanding of both the control and the nature of
menstruation. Many novel target molecules associated with
menstruation, such as the MMPs, VEGF, TIMPs and com-
ponents of the extracellular matrix, have been identified.
Exploration of these and other target molecules should lead
to a deeper understanding of severe menstrual blood loss,
and may lead to new suppressive therapies for HMB. Our
laboratory remains committed to this goal.
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